Zobrazeno 1 - 10
of 132
pro vyhledávání: '"M. A. Behr"'
Publikováno v:
Proceedings of the Design Society. 2:1835-1844
In an increasingly interconnected world, changes of uncertain nature and impact affect the functioning of human societies that depend on health, ecological, and economic systems. The proposed framework for systems-of-systems resilience explains ways
Publikováno v:
Pharmeuropa bioscientific notes. 2022
Due to the diminished stocks of the third batch of the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) for Human immunoglobulin for electrophoresis, in 2020 the European Directorate for the Quality of MedicinesHealthCare (EDQ
Autor:
J. Braun, M. Missler-Behr
Publikováno v:
2021 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM).
Autor:
M-E, Behr-Gross, B, Siklodi, D, Le Tallec, M, Halder, I, Manou, N, Sinitskaya, L, Bruckner, B, Dalmadi, L, Kiss, K, Redhead
Publikováno v:
Pharmeuropa bioscientific notes. 2021
During the production of clostridial vaccines large numbers of mice are used for various in-process control tests. Replacement in vitro assays had been developed for the testing of the toxins and toxoids of several clostridial species, but none of th
Publikováno v:
Pharmeuropa bioscientific notes. 2020
Three preparations of the human tumour necrosis factor (TNF) receptor II Fc fusion protein (TNFR II-Fc) Etanercept were formulated and lyophilised at the National Institute for Biological StandardsControl (NIBSC) prior to evaluation in a collaborativ
Publikováno v:
Pharmeuropa bioscientific notes. 2020
A project aimed at establishing replacement batches for the European Pharmacopoeia (Ph. Eur.) Biological Reference Preparation (BRP) Bordetella (B.) pertussis mouse antiserum was started in 2013 under the aegis of the Biological Standardisation Progr
Autor:
S, Morgeaux, N, Bornstein, C, Mourton-Gilles, P, Chagnaud, J, Charbonneau, J, Maurin, A, Daas, P, Variot, M-E, Behr-Gross
Publikováno v:
Pharmeuropa bioscientific notes. 2020
For acellular pertussis (aP) vaccines, the current European Pharmacopoeia (Ph. Eur.) monograph Pertussis vaccine (acellular, component, adsorbed) (1356) requires an immunogenicity assay in mice or guinea pigs to assess the potency of each lot of vacc
Publikováno v:
Pharmeuropa bioscientific notes. 2020
Large numbers of mice are used in testing during the production of Clostridial vaccines. Previous work has indicated that cell line assays could replace mouse tests for certain aspects of this testing. Replacement assays have been developed for the t
Publikováno v:
Pharmeuropa bioscientific notes. 2020
Two preparations of the chimeric anti-Tumour Necrosis Factor (TNF) monoclonal antibody Infliximab were formulated and lyophilised at the National Institute for Biological StandardsControl (NIBSC) prior to evaluation in a collaborative study for their
Publikováno v:
Pharmeuropa bio & scientific notes
Pharmeuropa bio & scientific notes, European Directorate for the Quality of Medicines & HealthCare, 2020, 2020, pp.125-140
Pharmeuropa bio & scientific notes, European Directorate for the Quality of Medicines & HealthCare, 2020, 2020, pp.125-140
International audience; Equine influenza (EI) is an important respiratory disease of horses, with welfare and economic consequences. Vaccination remains one of the most efficient prevention methods available. Equine influenza virus (EIV) is constantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::23917652ef9a6ac182d57f490648cfb9
https://hal-normandie-univ.archives-ouvertes.fr/hal-02931045
https://hal-normandie-univ.archives-ouvertes.fr/hal-02931045